CuTira brachytherapy: A new combination of radioactive copper isotopes and the hypoxic cytotoxin, tirapazamine, for targeted tumor therapy

Journal of Nuclear Medicine

Volumn 39, Issue 4, 1998, Pages 677-678

  Lin, Peck Sun ^a   Ho, Kwei Chi ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Copper isotopes; Hypoxic cytotoxin; Tirapazamine; Tumor therapy

Indexed keywords

COPPER COMPLEX; COPPER TIRAPAZAMINE CU 57; COPPER TIRAPAZAMINE CU 64; CYTOTOXIN; RADIOPHARMACEUTICAL AGENT; TIRAPAZAMINE; UNCLASSIFIED DRUG;

ARTICLE; BRACHYTHERAPY; CANCER STAGING; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG SELECTIVITY; HUMAN; HUMAN CELL; INTRAARTERIAL DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TUMOR LOCALIZATION;

BRACHYTHERAPY; HUMANS; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; TRIAZINES;

EID: 0031926053     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kukis DL, Diril H, Greiner DP, et al. A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates. Cancer 1994;73: 779-786.
2. Moi MK, DeNardo SJ, Meares CF. Stable bifunctional chelates of metals used in radiotherapy. Cancer Res 1990;50:789s-793s.
3. Anderson CJ, Connett JM, Schwarz SW, et al. Copper-64-labeled antibodies for PET imaging. J Nucl Med 1992;33:685-691.
4. Philpott GW, Schwarz SW, Anderson CJ, et al. Radioimmuno PET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J Nucl Med 1995;36:1818-1824.
5. Anderson CJ, Pajeau TS, Edwards WB, Sherman ELC, Rogers BE, Welch MJ. In vitro and in vivo evaluation of copper-64-octreotide conjugates. J Nucl Med 1995;36:2315-2325.
6. 67Cu. Proc Natl Acad Sci USA 1996;93: 6814-6818.
7. Lin PS, Ho KC. New cytotoxic mechanism of the bioreductivc agent tirapazamine (SR 4233) mediated by forming complex with copper. Radiat Oncol Investig 1996;4:211-220.
8. Doherty N, Hancock SL, Kaye S. et al. Muscle cramping in phase I clinical trials of, tirapazamme (SR 4233) with and without radiation. Int J Radiat Oncol Biol Phys 1994;29:379-382.
9. Lee DJ, Trotti A, Spencer S, et al. A phase II trial of radiotherapy with concurrent tirapazamine, a hypoxic cytotoxin, for advanced head and neck carcinomas [Abstract]. Int J Radiat Oncol Biol Phys 1996;36:202.
10. Young H, Carnochan P, Zweit J, Babich J, Cherry S, Ott R. Evaluation of copper (II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model. Eur J Nucl Med 1994;21:336-341.
11. Brown JM. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumors. Br J Cancer 1993;67:1163-1170.
12. 64Cu using a biomedical cyclotron. Nucl Med Biol 1997;24:35-43.
13. 67Cu. Int J Radiat Biol 1989;55:365-384.
14. Novell JR, Hilson A, Hobbs KEF. Therapeutic aspects of radio-isotopes in hepatobiliary malignancy. Br J Surg 1991;78:901-906.
15. Lartigau E, Guichard M. The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumors. Br J Cancer 1996;73:1480-1485.
16. Baas P, Oppelaar H, Stavenuiter M, Zandwijk NV, Stewart FA. Interaction of the bioreductive drug SR 4233 and photodynamic therapy using photofrin in a mouse tumor model. Int J Radiat Oncol Biol Phys 1993;27:665-670.
17. Bhattacharya S, Dhillon AP, Winslet MC, et al. Human liver cancer cells and endothelial cells incorporate iodised oil. Br J Cancer 1996;73:877-881.
18. Feun LG, Reddy KR, Yrizarry JM, et al. A phase I study of chemoembolization with cisplatin and lipiodol for primary and metastatic liver cancer. Am J Clin Oncol 1994;17:405-410.
19. Bhattacharya S, Novell JR, Winslet MC, Hobbs KEF. Iodized oil in the treatment of hepatocellular carcinoma. Br J Surg 1994;81:1563-1571.
20. Park JH, Jeon SC, Kang HS, Im JG, Han MC, Kim CW. Transcatheter renal arterial embolization with the mixture of ethanol and iodized oil (Lipiodol). Invest Radiol 1986;21:577-580.
21. Giorgio A, Tarantino L, Francica G, et al. Unilocular hydatid liver cysts: treatment with US-guided, double percutaneous aspiration and alcohol injection. Radiology 1992;184:705-710.
22. Ito K, Kusunoki H, Okamoto E, et al. Intra-arterial alcoholization of advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 1994;33(suppll):S42-S47.
23. Isobe H, Sakai H, Imari Y, Ikeda M, Shiomichi S, Nawata H. Intratumor ethanol injection therapy for solitary minute hepatocellular carcinoma. J Clin Gastroenterol 1994;18:122-126.
24. Arteel GL, Raleigh JA, Bradford BU, Thurman R. Acute alcohol produces hypoxia directly in rat liver tissue in vivo: role of Kupffer cells. Am J Physiol 1996;271:G494-G500.
25. Ebara M, Watanabe S, Kuta K, et al. MR imaging of small hepatocellular carcinoma: effect of intratumoral copper content on signal intensity. Radiology 1991;180:617-621.
26. 131I-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma. Cancer 1995;76:2202-2210.
27. Order SE, Stillwagon GB, Klein JL, et al. Iodine-131 antiferritin, a new treatment modality in hepatoma: a radiation therapy oncology group study. J Clin Oncol 1985;3:1573-1582.